Clinical trial NCT01255748: Registry Study for Radiation Therapy Outcomes
Official title: Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Neoplasms
Keywords: cancer, proton, radiation
Lead sponsor: Proton Collaborative Group
Sponsor class: NETWORK
First posted: 2010-12-07
Enrollment: 40000
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Radiation Oncology patients

Brief summary: The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.


Eligibility criteria: Inclusion Criteria:

* Planned treatment with radiation therapy
* Ability to understand and sign IRB approved consent

Primary outcomes:
measure: Define outcomes for patients treated at participating institutions
timeFrame: PRN
Secondary outcomes:
measure: Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures
timeFrame: Annually PRN
measure: Improve patient care by an adequate understanding of the results and patient population at participating institutions
timeFrame: Reviewed Annually PRN
Other outcomes:
Locations:
city: Scottsdale
country: United States
facility: Mayo Clinic
state: Arizona
city: San Diego
country: United States
facility: California Protons Cancer Therapy Center
state: California
city: Delray Beach
country: United States
facility: South Florida Proton Therapy Institute
state: Florida
city: Jacksonville
country: United States
facility: Ackerman Cancer Center
state: Florida
city: Miami
country: United States
facility: Miami Cancer Institute
state: Florida
city: Orlando
country: United States
facility: Orlando Health Cancer Institute
state: Florida
city: Atlanta
country: United States
facility: Emory Proton Therapy Center
state: Georgia
city: Warrenville
country: United States
facility: Northwestern Medicine Chicago Proton Center
state: Illinois
city: Kansas City
country: United States
facility: University of Kansas Proton Therapy Center
state: Kansas
city: Overland Park
country: United States
facility: Kansas City Proton Institute
state: Kansas
city: Shreveport
country: United States
facility: Willis-Knighton Cancer and Proton Therapy Center
state: Louisiana
city: Baltimore
country: United States
facility: Maryland Proton Treatment Center
state: Maryland
city: Flint
country: United States
facility: McLaren Proton Therapy Center
state: Michigan
city: Saint Louis
country: United States
facility: Washington University in St. Louis
state: Missouri
city: Somerset
country: United States
facility: ProCure Proton Therapy Center
state: New Jersey
city: New York
country: United States
facility: New York Proton Center
state: New York
city: Cincinnati
country: United States
facility: University of Cincinnati Medical Center
state: Ohio
city: Oklahoma City
country: United States
facility: Oklahoma Proton Center
state: Oklahoma
city: Franklin
country: United States
facility: Tennessee Oncology Proton Center
state: Tennessee
city: Knoxville
country: United States
facility: Thompson Proton Center
state: Tennessee
city: Fairfax
country: United States
facility: Inova Schar Cancer Institute
state: Virginia
city: Hampton
country: United States
facility: Hampton University Proton Therapy Institute
state: Virginia
city: Seattle
country: United States
facility: University of Washington
state: Washington
Study officials:
affiliation: Proton Collaborative Group
name: Carlos Vargas, MD
role: STUDY_CHAIR
References:
citation: Lee HJ Jr, Macomber MW, Spraker MB, Bowen SR, Hippe DS, Fung A, Russell KJ, Laramore GE, Rengan R, Liao J, Apisarnthanarax S, Zeng J. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes. Radiat Oncol. 2018 Sep 17;13(1):179. doi: 10.1186/s13014-018-1127-6.